Literature DB >> 29302747

Cytokine, chemokine and BDNF levels in medication-free pediatric patients with obsessive-compulsive disorder.

Rukiye Çolak Sivri1, Ayhan Bilgiç2, İbrahim Kılınç3.   

Abstract

The aim of this study was to investigate whether the serum levels of IL-12, IL-17, TGFβ, TNF-alpha, sTNFR1, sTNFR2, IL-1β, CCL3, CCL24, CXCL8, and BDNF are associated with obsessive-compulsive disorder (OCD) in medication-free children. A total of 44 (22 boys/22 girls) medication-free children with OCD and 40 (23 boys/17 girls) healthy controls were included in this study. The severity of the OCD symptoms were assessed by the Children's Yale-Brown Obsessive-Compulsive Scale and the Maudsley Obsessive-Compulsive Inventory. The Children's Depression Inventory and the Screen for Child Anxiety-Related Emotional Disorders were applied to the children in order to determine depression and anxiety levels. IL-17, IL-12, TGF β, TNF-alpha, sTNFR1, sTNFR2, IL-1β, CCL3, CCL24, CXCL8, and BDNF levels were measured by enzyme-linked immunosorbent assay. Multivariate analysis of covariance (MANCOVA) revealed a significant main effect on both groups for the levels of serum cytokine, chemokine, and BDNF, an effect that was independent of severities of depression and anxiety [Pillai's Trace V = 0.371, F (11, 70) = 3.756, p < 0.001, hp2 = 0.187]. Analysis of covariance (ANCOVA) indicated that serum TNF-alpha levels were significantly higher in the OCD group than in the control group (p < 0.001). In contrast, serum IL-12 levels were significantly lower in the OCD group than in the control group (p = 0.014). These findings suggest that TNF-alpha and IL-12 may play a role in the pathophysiology of OCD in children. The causal relationship between these proinflammatory cytokines and pediatric OCD requires further investigation.

Entities:  

Keywords:  Brain-derived neurotrophic factor; Chemokine; Children; Cytokine; Obsessive–compulsive disorder

Mesh:

Substances:

Year:  2018        PMID: 29302747     DOI: 10.1007/s00787-017-1099-3

Source DB:  PubMed          Journal:  Eur Child Adolesc Psychiatry        ISSN: 1018-8827            Impact factor:   4.785


  51 in total

Review 1.  Neurotrophins: roles in neuronal development and function.

Authors:  E J Huang; L F Reichardt
Journal:  Annu Rev Neurosci       Date:  2001       Impact factor: 12.449

Review 2.  New complexities in helper T cell fate determination and the implications for autoimmune diseases.

Authors:  Hiroaki Takatori; Yuka Kanno; Zhi Chen; John J O'Shea
Journal:  Mod Rheumatol       Date:  2008-08-05       Impact factor: 3.023

Review 3.  Childhood stressful events, HPA axis and anxiety disorders.

Authors:  Carlo Faravelli; Carolina Lo Sauro; Lucia Godini; Lorenzo Lelli; Laura Benni; Francesco Pietrini; Lisa Lazzeretti; Gabriela Alina Talamba; Giulia Fioravanti; Valdo Ricca
Journal:  World J Psychiatry       Date:  2012-02-22

4.  Plasma IL-12 levels are suppressed in vivo by stress and surgery through endogenous release of glucocorticoids and prostaglandins but not catecholamines or opioids.

Authors:  Lee Shaashua; Ella Rosenne; Elad Neeman; Liat Sorski; Luba Sominsky; Pini Matzner; Gayle G Page; Shamgar Ben-Eliyahu
Journal:  Psychoneuroendocrinology       Date:  2014-01-07       Impact factor: 4.905

5.  Psychiatric symptoms and proinflammatory cytokines in pregnancy.

Authors:  Emma Robertson Blackmore; Jan A Moynihan; David R Rubinow; Eva K Pressman; Michelle Gilchrist; Thomas G O'Connor
Journal:  Psychosom Med       Date:  2011-09-23       Impact factor: 4.312

Review 6.  Inflammation in children and adolescents with neuropsychiatric disorders: a systematic review.

Authors:  Rachel H B Mitchell; Benjamin I Goldstein
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2013-12-16       Impact factor: 8.829

7.  Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation.

Authors:  Hania Kebir; Katharina Kreymborg; Igal Ifergan; Aurore Dodelet-Devillers; Romain Cayrol; Monique Bernard; Fabrizio Giuliani; Nathalie Arbour; Burkhard Becher; Alexandre Prat
Journal:  Nat Med       Date:  2007-09-09       Impact factor: 53.440

8.  Increased serum levels of soluble tumor necrosis factor-alpha receptor-1 in patients with Parkinson's disease.

Authors:  Paula Scalzo; Arthur Kümmer; Francisco Cardoso; Antônio Lúcio Teixeira
Journal:  J Neuroimmunol       Date:  2009-09-03       Impact factor: 3.478

9.  High-anxious individuals show increased chronic stress burden, decreased protective immunity, and increased cancer progression in a mouse model of squamous cell carcinoma.

Authors:  Firdaus S Dhabhar; Alison N Saul; Tyson H Holmes; Christine Daugherty; Eric Neri; Jean M Tillie; Donna Kusewitt; Tatiana M Oberyszyn
Journal:  PLoS One       Date:  2012-04-25       Impact factor: 3.240

10.  Distinct Cytokine and Chemokine Profiles in Autism Spectrum Disorders.

Authors:  Yvonne M Y Han; Winnie K Y Cheung; Chun Kwok Wong; Sophia L Sze; Timmy W S Cheng; Michael K Yeung; Agnes S Chan
Journal:  Front Immunol       Date:  2017-01-23       Impact factor: 7.561

View more
  9 in total

1.  Immune Aberrations in Obsessive-Compulsive Disorder: a Systematic Review and Meta-analysis.

Authors:  Theodore D Cosco; Toby Pillinger; Hadeer Emam; Marco Solmi; Sanjay Budhdeo; A Matthew Prina; Michael Maes; Dan J Stein; Brendon Stubbs; Andre F Carvalho
Journal:  Mol Neurobiol       Date:  2018-10-31       Impact factor: 5.590

Review 2.  Individualized Immunological Data for Precise Classification of OCD Patients.

Authors:  Hugues Lamothe; Jean-Marc Baleyte; Pauline Smith; Antoine Pelissolo; Luc Mallet
Journal:  Brain Sci       Date:  2018-08-09

Review 3.  Diagnostic Issues in Early-Onset Obsessive-Compulsive Disorder and their Treatment Implications.

Authors:  Elisabetta Burchi; Stefano Pallanti
Journal:  Curr Neuropharmacol       Date:  2019       Impact factor: 7.363

Review 4.  Obsessive-Compulsive Disorder With Rheumatological and Inflammatory Diseases: A Systematic Review.

Authors:  Ahmed M Alsheikh; Maram M Alsheikh
Journal:  Cureus       Date:  2021-05-01

Review 5.  Cytokine profile of pediatric patients with obsessive-compulsive and/or movement disorder symptoms: A review.

Authors:  Rebecca Alison Fabricius; Camilla Birgitte Sørensen; Liselotte Skov; Nanette Mol Debes
Journal:  Front Pediatr       Date:  2022-08-19       Impact factor: 3.569

6.  Lower serum levels of IL-1β and IL-6 cytokines in adolescents with anorexia nervosa and their association with gut microbiota in a longitudinal study.

Authors:  Hannah E Specht; Nina Mannig; Meriem Belheouane; Nadia Andrea Andreani; Klaus Tenbrock; Ronald Biemann; Katrin Borucki; Brigitte Dahmen; Astrid Dempfle; John F Baines; Beate Herpertz-Dahlmann; Jochen Seitz
Journal:  Front Psychiatry       Date:  2022-08-18       Impact factor: 5.435

7.  Cytokine alterations in pediatric internalizing disorders: Systematic review and exploratory multi-variate meta-analysis.

Authors:  Aaron S Howe; David A Lynch
Journal:  Brain Behav Immun Health       Date:  2022-07-16

8.  Increased serum brain-derived neurotrophic factor and adrenocorticotropic hormone levels are associated with obsessive compulsive disorder in medication‑free children.

Authors:  Ayhan Bilgiç; Merve Sertdemir; İbrahim Kılınç; Ömer Faruk Akça
Journal:  Eur Child Adolesc Psychiatry       Date:  2021-01-02       Impact factor: 4.785

Review 9.  Obsessive-compulsive disorder in children and adolescents: epidemiology, diagnosis and management.

Authors:  Ahsan Nazeer; Finza Latif; Aisha Mondal; Muhammad Waqar Azeem; Donald E Greydanus
Journal:  Transl Pediatr       Date:  2020-02
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.